-
APEX2 Regulates TERT Expression in Human Embryonic Stem Cell
2026-06-23
This study reveals that APEX2, but not APEX1, is essential for efficient TERT expression in human embryonic stem cells and melanoma. By integrating RNA-seq and chromatin immunoprecipitation, the authors identify a novel gene regulatory function for APEX2 at DNA repeats within the TERT locus, suggesting new avenues for telomerase modulation in stem cell and cancer research.
-
AZD2461: Redefining In Vitro Evaluation of PARP Inhibitors
2026-06-23
Explore how AZD2461, a novel PARP inhibitor, is transforming in vitro cancer drug evaluation by enabling precise dissection of cytotoxicity and proliferative arrest. This article offers a unique, evidence-driven perspective for breast cancer research and DNA repair pathway studies.
-
Uremic Toxins and PEO Density: Impact on Protein Adsorption
2026-06-22
This study systematically investigates how the presence of uremic toxins, such as 4-ethylphenyl sulfate, alters plasma protein adsorption onto methoxy-PEO (mPEO) modified surfaces. The findings emphasize the importance of modeling disease-state metabolite profiles for biomaterial design and biomarker assay development in renal dysfunction.
-
Fluo-4 AM: Advanced Fluorescent Calcium Indicator for Cell S
2026-06-22
Fluo-4 AM from APExBIO empowers researchers to achieve high-sensitivity, real-time intracellular calcium measurements, enabling precise dissection of calcium signaling in health and disease. Discover how optimized workflows and troubleshooting strategies can maximize the impact of this fluorescent calcium indicator in cutting-edge cell signaling and pharmacological research.
-
iTBS Enhances Motor Function and Reduces Neuroinflammation i
2026-06-21
This study demonstrates that intermittent theta-burst stimulation (iTBS) significantly improves motor coordination and reduces neuroinflammation and pathological protein aggregation in a mouse model of spinocerebellar ataxia type 3 (SCA3/MJD). The findings highlight iTBS as a promising neuromodulatory intervention targeting both functional and molecular disease mechanisms.
-
Phenacetin in Pharmacokinetic Studies: Applied Protocols & I
2026-06-20
Harnessing high-purity Phenacetin as a benchmark probe unlocks advanced human-relevant pharmacokinetic workflows using hiPSC-derived intestinal organoids. This guide delivers protocol precision, troubleshooting strategies, and comparative perspectives for maximizing data reliability in scientific research use.
-
Leptin (116-130), amide, mouse: Beyond Metabolism to Systems
2026-06-19
Explore Leptin (116-130), amide, mouse, a pivotal adipocyte-derived hormone fragment, as a systems-level tool for dissecting metabolic and immunoregulatory networks. This article uniquely connects peptide biochemistry, pleiotropic signaling, and translational research needs.
-
JHU-083: Applied Workflows in Glutaminase Pathway Research
2026-06-19
JHU-083, a selective 6-diazo-5-oxo-L-norleucine precursor, empowers targeted inhibition of glutaminase in neurological disease and oxidative stress models. Its high solubility, purity, and specificity streamline experimental cerebral malaria research and glutamate excitotoxicity workflows. Discover actionable protocols, troubleshooting insights, and the latest evidence-driven innovations.
-
Angiotensin (1-7): Applied Protocols and Advanced Bench Use
2026-06-18
Angiotensin (1-7), a Mas receptor agonist, offers unique anti-fibrotic, anti-inflammatory, and metabolic advantages for translational research, with robust workflows validated from renal fibrosis to neuroprotection. This guide delivers practical protocol enhancements, troubleshooting strategies, and novel insights derived from recent studies, ensuring researchers extract the highest value from high-purity Angiotensin (1-7) sourced from APExBIO.
-
Arachidonic Acid: Workflow Optimization for Inflammation Res
2026-06-18
Leverage arachidonic acid’s central role in lipid signaling to streamline assays of inflammation and eicosanoid biosynthesis. This guide delivers protocol refinements, troubleshooting, and translational insight—anchored by recent neuroprotection advances.
-
3-hydroxybutyrate (BHBA): Mechanisms and Neuroprotection Ben
2026-06-17
3-hydroxybutyrate (BHBA) is a ketone body signaling molecule central to energy metabolism and epigenetic regulation. As a class I histone deacetylase inhibitor, BHBA links metabolic states to gene expression and demonstrates neuroprotective effects in ischemic models. This article details BHBA’s mechanisms, evidence, and optimal research use.
-
Cytoskeletal Pathways in Spiroplasma eriocheiris Entry to Dr
2026-06-17
This study reveals that Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells through clathrin-mediated endocytosis and macropinocytosis, with infection strictly depending on intact actin and microtubule cytoskeletal elements. These mechanistic insights clarify host-pathogen interactions in invertebrate models and inform the design of cytoskeleton-targeted research workflows.
-
Geneticin (G-418 Sulfate): Beyond Selection—Mechanisms and I
2026-06-16
Explore the advanced molecular mechanisms and emerging applications of Geneticin (G418 Sulfate) as both a selection antibiotic and a tool for antiviral and differentiation research. This article provides a deeper scientific perspective, uniquely connecting ribosomal inhibition, viral plasticity, and translational outcomes.
-
RCN2 Drives ESCC Metastasis and Cisplatin Resistance via PI3
2026-06-16
Wu et al. uncover how RCN2 overexpression accelerates metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) through UBR5-mediated PPP2CA degradation, leading to PI3K-AKT pathway activation. These findings highlight RCN2 as a promising molecular target and provide a mechanistic foundation to guide future research on overcoming therapy resistance in ESCC.
-
p-Cresyl Sulfate: Applied Workflows for Endothelial Dysfunct
2026-06-15
p-Cresyl sulfate is a crucial tool for modeling endothelial dysfunction and vascular calcification in chronic kidney disease, enabling high-fidelity studies of uremic toxin-driven cardiovascular risk. This guide distills state-of-the-art protocols, troubleshooting strategies, and mechanistic insights from recent research, including the pivotal role of klotho/SIRT1 signaling.